Li Li,1,2 Yajing Chen,1 Gaixia Xu,2,3 Dongmeng Liu,1 Zhiwen Yang,1 Tingting Chen,1 Xiaomei Wang,1 Wenxiao Jiang,1 Dahui Xue,1 Guimiao Lin1

1Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, Shenzhen Key Laboratory of Synthetic Biology, Department of Physiology, School of Basic Medical Sciences, Shenzhen University, Shenzhen 518055, Peoples Republic of China; 2Key Laboratory of Optoelectronics Devices and Systems of Ministry of Education/Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, Peoples Republic of China; 3Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen 518055, Peoples Republic of China

Correspondence: Guimiao LinSchool of Basic Medical Sciences, Shenzhen University Health Sciences Center, Shenzhen 518060, Peoples Republic of ChinaTel/ Fax +86-755-86671903Email gmlin@szu.edu.cn

Introduction: Indium phosphide (InP) quantum dots (QDs) have shown a broad application prospect in the fields of biophotonics and nanomedicine. However, the potential toxicity of InP QDs has not been systematically evaluated. In particular, the effects of different surface modifications on the biodistribution and toxicity of InP QDs are still unknown, which hinders their further developments. The present study aims to investigate the biodistribution and in vivo toxicity of InP/ZnS QDs.Methods: Three kinds of InP/ZnS QDs with different surface modifications, hQDs (QDs-OH), aQDs (QDs-NH2), and cQDs (QDs-COOH) were intravenously injected into BALB/c mice at the dosage of 2.5 mg/kg BW or 25 mg/kg BW, respectively. Biodistribution of three QDs was determined through cryosection fluorescence microscopy and ICP-MS analysis. The subsequent effects of InP/ZnS QDs on histopathology, hematology and blood biochemistry were evaluated at 1, 3, 7, 14 and 28 days post-injection.Results: These types of InP/ZnS QDs were rapidly distributed in the major organs of mice, mainly in the liver and spleen, and lasted for 28 days. No abnormal behavior, weight change or organ index were observed during the whole observation period, except that 2 mice died on Day 1 after 25 mg/kg BW hQDs treatment. The results of H&E staining showed that no obvious histopathological abnormalities were observed in the main organs (including heart, liver, spleen, lung, kidney, and brain) of all mice injected with different surface-functionalized QDs. Low concentration exposure of three QDs hardly caused obvious toxicity, while high concentration exposure of the three QDs could cause some changes in hematological parameters or biochemical parameters related to liver function or cardiac function. More attention needs to be paid on cQDs as high-dose exposure of cQDs induced death, acute inflammatory reaction and slight changes in liver function in mice.Conclusion: The surface modification and exposure dose can influence the biological behavior and in vivo toxicity of QDs. The surface chemistry should be fully considered in the design of InP-based QDs for their biomedical applications.

Keywords: InP/ZnS quantum dots, surface chemistry, in vivo, biodistribution, nanotoxicology

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

View original post here:
In vivo Comparison of the Biodistribution and Toxicity of InP/ZnS Quan | IJN - Dove Medical Press

There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.

Since the outbreak began in late 2019, researchers have been racing to learn more about SARS-CoV-2, which is a strain from a family of viruses known as coronavirus for their crown-like shape.

Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a contingency of scientists that are contributing ideas and technology to the Centers for Disease Control and Prevention to fight the COVID-19 outbreak.

Professor and chair of the Department of Chemical Engineering Tom Webster. Photo by Adam Glanzman/Northeastern University

The idea of using nanoparticles, Webster says, is that the virus behind COVID-19 consists of a structure of a similar scale as his nanoparticles. At that scale, matter is ultra-small, about ten thousand times smaller than the width of a single strand of hair.

Webster is proposing particles of similar sizes that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment. That structural change would then halt the ability of the virus to survive and reproduce in the body.

You have to think in this size range, says Webster, Art Zafiropoulo Chair of chemical engineering at Northeastern. In the nanoscale size range, if you want to detect viruses, if you want to deactivate them.

Finding and neutralizing viruses with nanomedicine is at the core of what Webster and other researchers call theranostics, which focuses on combining therapy and diagnosis. Using that approach, his lab has specialized in nanoparticles to fight the microbes that cause influenza and tuberculosis.

Its not just having one approach to detect whether you have a virus and another approach to use it as a therapy, he says, but having the same particle, the same approach, for both your detection and therapy.

SARS-CoV-2 spreads mostly through tiny droplets of viral particlesfrom breathing, talking, sneezing, coughingthat enter the body through the eyes, mouth, or nose. Preliminary research also suggests that those germs may survive for days when they attach themselves to countertops, handrails, and other hard surfaces.

Thats one reason to make theranostics with nanoparticles the focus of the COVID-19 outbreak, Webster says.

Nanoparticles can disable these pathogens even before they break into the body, as they hold on to different objects and surfaces. His lab has developed materials that can be sprayed on objects to form nanoparticles and attack viruses.

Even if it was on a surface, on someones countertop, or an iPhone, he says. It doesnt mean anything because its not the active form of that virus.

That same technology can be fine-tuned and tweaked to target a wide range of viruses, bacteria, and other pathogens. Unlike other novel drugs with large molecular structures, nanoparticles are so small that they can move through our body without disrupting other functions, such as those of the immune system.

Almost like a surveyor, they can go around your bloodstream, Webster says. They can survey your body much easier and under much longer times and try and detect viruses.

To do all that, the CDC needs to know the specifics about what kind of structure is needed to neutralize SARS-CoV-2, Webster says. That information isnt public yet.

You have to identify what we need to put in our nanoparticle to attract it to that virus, he says. The CDC must know that, because theyve developed a kit that can determine if you have [COVID-19], versus influenza, or something else.

An alternative to nanomedicine is producing synthetic molecules. But Webster says that tactic presents some challenges. In the case of chemotherapies used to treat cancer cells, such synthetic drugs can cause severe side effects that kill cancer cells, as well as other cells in the body.

The same thing could be happening with synthetic chemistry to treat a virus, where molecules are killing a lot more than just that virus, Webster says.

Still, Webster acknowledges that there arent many researchers focusing on nanoparticles to kill viruses.

One of the main reasons for the lack of those solutions is that the same benefits that make nanoparticles ideal to fight infectious diseases also make them a concern for the U.S. Federal Drug Administration.

Because of their size, nanoparticles are pervasive (too pervasive, maybe) to seep through other parts of the body. To reduce that risk, Websters lab has focused on using iron oxide. Particles of that make up entail chemistry that is already natural to our bodies and diets.

Even if you have a viral infection, you need more iron, because you could be anemic depending on how bad the infection is, Webster says. Were actually developing these nanoparticles out of chemistries that can help your health.

And, he says, iron-based nanoparticles could be directed with magnetic fields to target specific organs in the body, such as lungs and other areas susceptible to respiratory complications after contracting viral infections. That too, Webster says, is something that you couldnt do with a novel synthetic molecule.

Really, what this all means is that we just have to do the studies to show those iron nanoparticles are not going into the brain or the kidney, Webster says, that these nanoparticles are going exactly where you want them to go to the virus.

For media inquiries, please contact Shannon Nargi at s.nargi@northeastern.edu or 617-373-5718.

Go here to read the rest:
Here's how nanoparticles could help us get closer to a treatment for COVID-19 - News@Northeastern

WEST PALM BEACH, FL Among patients with relapsing multiple sclerosis (MS) and visual impairment who received a potential remyelinating treatment or placebo for as long as 36 weeks, median low-contrast letter acuity improved in the population overall, according to an interim, blinded analysis.

Exploratory outcome measures of cognition, gait, and upper extremity function also improved.

The results do not mean that the treatment works. "We know that placebo works. I'm not here to tell you that the drug works. I'm just here to tell you that we have intriguing data," said Robert Glanzman, MD, chief medical officer of Clene Nanomedicine, the developer of the drug.

The patients in the interim analysis represent about 25% of the target study population of 150 patients, Glanzman said. The phase 2, double-blind, randomized, controlled trial, VISIONARY-MS, is assessing the efficacy and safety of CNM-Au8, a suspension of clean-surfaced gold nanocrystals that may support intracellular biologic processes. Patients are randomly assigned to receive low-dose CNM-Au8, high-dose CNM-Au8, or placebo taken orally once daily.

Neuroprotective or remyelinating agents are an unmet need in MS, Glanzman said. VISIONARY-MS has enrolled patients at centers in Australia and recently expanded the trial sites in North America. He presented the interim data during a joint symposium of the North American Imaging in MS Cooperative and the International Multiple Sclerosis Visual System Consortium at the meeting held by the Americas Committee for Treatment and Research in Multiple Sclerosis.

VISIONARY-MS is enrolling participants with chronic optic neuropathy, defined as visual impairment with no episodes of acute optic neuritis within the 6 months prior to enrollment, and nonactive disease, defined as no MS relapses within the prior 3 months. Patients may take concomitant immunomodulatory disease-modifying MS therapies during the trial.

The primary endpoint is improvement in low-contrast letter acuity (LCLA) from baseline to week 24. Secondary endpoints are change in amplitude and latency of multifocal visual evoked potential. Other functional measures are exploratory endpoints. Participants remain in the trial through week 48 or until the last participant completes week 24.

Among the first 34 enrolled participants, median LCLA improved by about five letters, Glanzman said.

Patients also had median improvement on other subscales of the modified Multiple Sclerosis Functional Composite (MSFC) that assess cognition (Symbol Digit Modalities Test), upper extremity function (9-Hole Peg Test), and gait (Timed 25-foot Walk).

CNM-Au8 has been well tolerated, and no serious adverse events related to the study drug have been reported. The most frequent adverse events include headache, upper respiratory infection, and sore throat. Full unblinded results are anticipated in 2021.

About 60% of patients in the interim analysis were female, and the mean Expanded Disability Status Scale score was less than 2, Glanzman said.

"These data add to the growing body of clinical evidence demonstrating that CNM-Au8, a suspension of catalytic, clean-surfaced, faceted gold nanocrystals, has the unique ability to improve remyelination and provide axonal neuroprotection," Glanzman said in a news release. "The consistent median improvements observed across the MSFC functional domains in the population of participants in VISIONARY-MS are exciting."

At previous meetings, research has described data from studies that have provided evidence of efficacy in animal models of MS. An overview of the preclinical studies "Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis" was published recently in Scientific Reports. Preclinical studies in animal models of diseases other than MS also have shown evidence of neuroprotection, Glanzman said.

"We are studying the visual system in order to interrogate the nervous system as a whole," he said. "The visual system is by far the most sensitive to change." The design of VISIONARY-MS was informed by a trial of clemastine fumarate as a potential remyelinating agent in patients with chronic optic neuropathy, Glanzman added.

Glanzman is an employee of Clene Nanomedicine, and receives salary and stock options.

Source: 5th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020. Abstract.

This story originally appeared on MDedge.com.

Read the original:
Phase 2 Remyelination Trial Yields 'Intriguing' Interim Results - Medscape

Nanowires Market(2020 2023) report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The Nanowires market report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Nanowires Marketreport is anticipated to register aCAGR ofXX%over a five years forecast period (2020 2023).

Get a Sample PDF of Report @https://www.360marketupdates.com/enquiry/request-sample/12884845

List of Major Key playersoperating in the Global Nanowires Market are

The global nanowires market is expected to grow at a significant rate during the forecast period (2020 2023), majorly driven by the emerging applications of nanowires in LEDs, nano-medicines, and consumer electronics. Nanowires are the building blocks for the next generation of consumer electronics, photonics, sensors (both biological and chemical), and renewable energy applications.

Emerging Applications of Nanowires in LEDs, Nano-medicines, and Consumer Electronics Drive the Market

Nanowires, due to properties, such as, high crystallinity, high surface to volume to ratio, and high resistance, nanowires are increasingly being used in nanomedicines, biomedicine, consumer electronics, bioelectronics, etc. Their use has helped to propel the field of nanomedicine. Nanomedicine is defined as the application of nanotechnology for diagnosis, monitoring, drug delivery, treatment, and control of biological systems. In the United States, the Food & Drug Administrator (FDA) approved over 100 nanodrugs for use in medicinal trials and clinical treatment. Also, nanowires are now increasingly being used in LEDs. They allows for faster communication between devices and microchips. These emerging applications of nanowires in LEDs, consumer electronics, and nano medicines are expected to contribute to the growth of the global nanowires market during the forecast period.

Metal Nanowires to Dominate the Market

Metals have unique thermal, mechanical, electrical, and catalytic properties. On the other hand, metallic nanowires are promising materials for a variety of applications, such as, transparent conductive films for photovoltaic devices, electrodes for batteries, and nano-reinforcement for composite materials. Electronics is one of the major end-user applications of nanowires. They are used in transistors as they are very good conductors or semiconductors. They are also expected to play a significant role in quantum computers in the near future. Moreover, new applications of metal nanowires are also being developed in the field of energy.

China dominates the nanowires Market

China is expected to be the largest market for nanowires, as the country has been engaging in R&D activities for the development of nanotechnology. Nanomaterial regulations in China have helped develop advanced nanomaterial, for the development of environment-friendly products, which are expected to reduce exhaust emissions. The country has a higher usage of nanowires in applications, such as, electrical & electronics, construction, healthcare, and aerospace. In China, about 2,570 jets are used commercially. It is one of the fastest growing aviation industries with a consistent increase in passenger traffic at about 6.6% per year. These advanced technological developments in numerous applications are expected to boost the growth of the nanowires market, during the forecast period.

Share your query before purchasing this report @https://www.360marketupdates.com/enquiry/pre-order-enquiry/12884845

Scope of the Report:

The report analyses Nanowires market, which includes

Highlighted points of Nanowires Market Report:

Purchase this report (Price 4250 USD for a single-user license)@https://www.360marketupdates.com/purchase/12884845

Reasons to Purchase Nanowires Market Report:

In this study, the years considered to estimate the market size of Nanowires:

History Year: 2013-2017Base Year: 2017Estimated Year: 2020Forecast Year 2020 to 2023

Look into Table of Content of Nanowires Market Report @https://www.360marketupdates.com/TOC/12884845#TOC

Contact Info:

360 Market Updates

Mr. Ajay More

USA: +1 424 253 0807

UK: +44 203 239 8187

[emailprotected]

Tags:-Nanowires, Nanowires Market, Nanowires Europe Market, Nanowires APAC Market, Nanowires Market By Application, Nanowires Market By Rising Trends, Nanowires Market Development, Nanowires Market Forecast, Nanowires Market Future, Nanowires Market Growth, Nanowires Market In Key Countries, Nanowires Market Latest Report, Nanowires Market Swot Analysis, Nanowires Market Top Manufacturers, Nanowires Sales Market, Nanowires United States Market, Nanowires Market share, Nanowires Market Size, Nanowires market Trends, Nanowires Market 2020, Nanowires market 2019

OUR OTHER REPORTS:-

Global Barcode Label Printer Market 2020 Industry Price Trend, Size Estimation, Industry Outlook, Business Growth, Report Latest Research, Business Analysis and Forecast 2024 Analysis Research | 360 Market Updates

Release Liners Market 2020 by Top Countries Data: Industry Analysis by Regions, Revenue, Share, Development, Tendencies and Forecast to 2024 360 Market Updates

Medical Tourism Market 2020: Emerging Technologies, Sales Revenue, Key Players Analysis, Development Status, Opportunity Assessment and Industry Expansion Strategies 2024 | 360 Market Updates

Power Sunroof Market 2020: New Project SWOT Analysis, Market Size, Investment Feasibility Analysis, Future Forecast 2024 360 Market Updates

Pharmaceutical Autoclaves Market 2020 to 2024 Production and Market Share by Type and Top Companies 360 Market Updates

Disposable Laparoscopic Trocar Market Report 2020: Market Analysis by Raw Materials Sources, Major Manufacturers, Export and Import by Regions 360 Market Updates

Barcode Label Printer Market: Global Industry Research, Size, Share, Growth, Trends, and Forecast, 20202024 360 Market Updates

Read more here:
Global Nanowires Market 2020 is Anticipated to Reach US$ XX% by 2023 - The KPM News

In this column, Ill be highlighting some of the research presented at this years Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held last week in West Palm Beach, Florida.

Youll need to read to the end of this news story to get to the most interesting information. The researchers data indicate that human glial progenitor cells can be transplanted into areas of the central nervous systems of mice where myelin has been damaged, to remyelinate them. Its worth a long read to see how the researchers support their conclusions.

Transplanting humanglial progenitor cells (GPCs) brain cells able to generate myelin-producing cells effectively led to remyelination in the brains of adult mice with myelin disorders, a study found.

These results were presented atthe Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020, running Feb 2729 in Florida,by John Mariani, PhD, with the University of Rochester.

His presentation was titled Human Glial Progenitor Cells Effectively Remyelinate The Demyelinated Adult Brain.

Click here to read the full story.

***

Heres another early study about myelin. This one involves an agent thats designed to increase energy reserves within neurons and myelin-producing cells, or oligodendrocytes, while decreasing toxic metabolic byproducts. Its expected that the process will improve the survival and function of those neurons and support the ability of oligodendrocytes to create new myelin.

Clene Nanomedicine shared early results of the VISIONARY-MS trial, suggesting that CNM-Au8 an investigational remyelinating therapy leads to notable trends in better vision, as well as benefits in mobility and manual function in relapsing multiple sclerosis(MS) patientswith chronic vision problems.

These findings were presented during the Joint NAIMS-IMSVISUAL Symposium at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020, running Feb. 2729 in Florida, by Robert Glanzman, MD, Clenes chief medical officer.

Preclinical tests in mice demonstrated that CNM-Au8 stimulatesthe production of new myelin, and increases the number of myelin-wrapped nerve fibers in the brain and spinal cord, allowing animals to recover motor skills.

Click here to read the full story.

***

Id expect that worsening neurological function would result in depression, but Im surprised to read that it may also be the other way around that depression may cause neurological function to decline. These researchers found that individuals who began their study being depressed had a 20 percent or greater chance than others of having one or more of their neurological performance scores worsen a year later.

Multiple sclerosis (MS) patients with depression are more likely to have worsening neurological function compared with those who do not have the mood disorder, results from a real-world study show.

The findings were presented Feb. 27 by Jenny Feng, MD, in an oral presentation titled Depression In MS Is Associated With Worsening Neuroperformance, Relapses, And New Brain Lesions at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020, taking place Feb. 27-29 in West Palm Beach, Florida.

Click here to read the full story.

***

The U.S. Food and Drug Administration is expected to decide by June whether to approve the disease-modifying therapy ofatumumab, while the European Medicines Agencys decision is expected sometime in 2021. Ofatumumab is a fully human monoclonal antibody that binds to the CD20 marker on certain B-cells, depleting those cells a process similar to the way Ocrevus (ocrelizumab) works.

Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will review Novartis applications seeking regulatory approval of ofatumumab, aninvestigational B-cell therapy for the treatment of relapsing forms ofmultiple sclerosis(MS) in adults.

Novartis applications for ofatumumab which has the potential to become a first-choice treatment for relapsing MS patients, easily self-administered using an autoinjector pen were accepted by both the U.S. and EU regulatory agencies.

Click here to read the full story.

***

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.

Ed Tobias is a retired broadcast journalist. Most of his 40+ year career was spent as a manager with the Associated Press in Washington, DC. Tobias was diagnosed with Multiple Sclerosis in 1980 but he continued to work, full-time, meeting interesting people and traveling to interesting places, until retiring at the end of 2012.

Excerpt from:
MS News that Caught My Eye Last Week: Remyelination Research in... - Multiple Sclerosis News Today

Nanomedicine Market Global Industry Report 2020 offer target audience with the fresh outlook on market and fill in the knowledge gaps with the help of processed information and opinions from industry experts. The information in the research report is well-processed and a report is accumulated by industry professionals and seasoned experts in the field to ensure of the quality of research.

Get a Sample Copy of this Report at https://www.orianresearch.com/request-sample/1035385

Development policies and plans are discussed as well as growth rate, manufacturing processes, economic growth are analyzed. This research report also states import/export data, industry supply and consumption figures as well as cost structure, price, industry revenue (Million USD) and gross margin by regions.

Nanomedicine Market Important Factors:

Global Nanomedicine Market: Regional Analysis:

The report offers in-depth assessment of the growth and other aspects of the Nanomedicine market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

For competitor segment, the report includes global key players of Nanomedicine Market as well as some small players. The information for each competitor includes:

Global Nanomedicine Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period 2020-2026

Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/1035385

Market segment by Type, the product can be split into

Market segment by Application, split into

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the Nanomedicine market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market experts opinions have been taken to understand the Nanomedicine market better.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Get Full Copy of This Report @ https://www.orianresearch.com/checkout/1035385

In this study, the years considered to estimate the market size of Nanomedicine are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

Table of Contents Nanomedicine Market Research Report is:

1 Nanomedicine Market Report Overview

2 Global Nanomedicine Market Growth Trends

3 Nanomedicine Market Share by Key Players

4 Nanomedicine Market Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Nanomedicine Market Forecast 2020-2026

14 Analysts Viewpoints/Conclusions

15 Appendix

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Email: [emailprotected]

Read the rest here:
Nanomedicine Market 2020: by Top Manufactures, Production, Consumption, Trade Statistics, Growth Analysis, Industry Share and Forecast to 2026 - Daily...

Nanomedicine Biology Summative

By: Marshaye Francis

Read the rest here:
Nanomedicine Biology Summative - Video

WATERLOO A University of Waterloo researcher is combining 3D printing and his expertise in nanomedicine to create a novel way to protect women from getting HIV.

Emmanuel Ho, an associate professor in UW's School of Pharmacy, is developing an intra-vaginal ring that would provide precise doses of medication that could stop HIV infection at the site of transmission.

"This will empower women to protect themselves," Ho said.

The ring is made of medical-grade plastic with hollow tubing and tiny pores. Medicine loaded into the ring, which is placed in the vagina, is slowly released and absorbed by the body.

Ho is testing a combination of anti-HIV and anti-inflammatory drugs. Inflammation in the vagina increases the risk of acquiring HIV because inflammation draws the immune cells that are infected by the virus.

"If a woman has high levels of inflammation in the genital tract, then the probability of HIV infection is much higher," said Ho's collaborator Keith Fowke, professor and head of Medical Microbiology and Infectious Diseases at the University of Manitoba.

Releasing anti-inflammation medication directly could reduce the risk, and then the anti-HIV medication could combat the virus if a woman is infected.

"It's kind of like a two-pronged approach," Ho said.

Intra-vaginal rings with a similar shape and design, such as NuvaRing, have been approved for birth control and hormone replacement therapy.

However, Ho said a 3D printed model allows for more precise design and drug delivery. It's also cheaper and avoids the waste from traditional manufacturing where melted polymers are poured into a mould.

Ho's ring could be used for a variety of medications, including hormonal contraceptives. Delivering it to the site would reduce the amount of medication needed, which would mean fewer side-effects.

Condoms and anti-HIV treatment are available to prevent HIV infection. But social and cultural factors can impede condom use, no to mention availability in developing countries, and oral medications need to be taken daily.

The ring would offer a discrete, effective and convenient approach.

"This would be a new option," Ho said.

The research recently got a grant from the Canadian government to move onto animal testing with the University of Manitoba and the Centers for Disease Control and Prevention in the United States, bringing it one step closer to reality from concept.

Globally, infection rates are on the rise for HIV the virus that causes AIDS and kills one million people globally each year, according to UNAIDS.

"There's a definite need," Ho said.

jweidner@therecord.com

Twitter: @WeidnerRecord

jweidner@therecord.com

Twitter: @WeidnerRecord

Read more from the original source:
3D printing and nanomedicine combined to combat HIV - TheRecord.com

#2 Cutting Edge of Science, Homeopathy Nanomedicine
Part 2: A presentation at San Francisco #39;s prestigious Commonwealth Club (September 17, 2014). The body of evidence for homeopathy and nanopharmacology is so much larger than most people ...

By: Dana Ullman

More here:
#2 Cutting Edge of Science, Homeopathy & Nanomedicine - Video

The Nanomedicine Toolkit
https://store.theartofservice.com/the-nanomedicine-toolkit.html This innovative set of documents and ready-to-use templates will provide you with a head star...

By: TheArtofService

Excerpt from:
The Nanomedicine Toolkit - Video

To provide the global outlook of the Nanomedicine Market a new statistical study has added by HealthCare Intelligence Markets to its massive database. During the analysis of this market the existing industries, as well as upcoming start-ups, have been considered. It helps to make informed decisions in the businesses. Well explained Porters five analysis and SWOT analysis have been used by a researcher of the report. The research report is comprised market trends and holistic business information that can pinpoint market pinpoint analysis along with revenue, growth, and profit over a predictable period. This provides a complete analysis of driver, paper and market opportunities.

Ask for sample copy of this [emailprotected]https://www.healthcareintelligencemarkets.com/request_sample.php?id=24150

Profiling Key players: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd.

It relates to new Nanomedicine Market competitors and recognized players. This report includes the Nanomedicine Market situation and forecasts of global and key regions, with the introduction of vendors, regions, product types and end enterprises and this report calculates product types and final industry in the world and major regions.

This market report includes analysts, managers, Nanomedicine Market industry experts, and access research that is designed to help key people view graphs and tables, as well as data that records the resources needed to conduct their own analysis. This report, which deals with information integration and research potential with results, predicted a strong rise in this market in the product section and in all regions.

Ask for a discount on this [emailprotected]https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=24150

Highlights of the Report:

Lastly, this report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.

For more information ask our experts @https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=24150

If you have any special requirements, please let us know and we will offer you the report as per your requirements.

About Us:

HealthCare Intelligence Markets Reports provides market intelligence & consulting services to a global clientele spread over 145 countries. Being a B2B firm, we help businesses to meet the challenges of an ever-evolving market with unbridled confidence. We craft customized and syndicated market research reports that help market players to build game-changing strategies. Besides, we also provide upcoming trends & future market prospects in our reports pertaining to Drug development, Clinical & healthcare IT industries. Our intelligence enables our clients to make decisions with which in turn proves a game-changer for them. We constantly strive to serve our clients better by directly allowing them sessions with our research analysts so the report is at par with their expectations.

Contact Us:Address: 90, State Office Center,90, State Street Suite 700,Albany, NY 12207Email:[emailprotected]Website:www.healthcareintelligencemarkets.comPhone:+1 (888) 616-2766

https://farmingsector.co.uk/

See the original post:
Meticulous Report on Nanomedicine Market 2021-2027 | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc.,...

NANOMEDICINE HANGOUT

By: John Bennett

Link:

NANOMEDICINE HANGOUT - Video

Mining Genome Information for New Starting Points in Personalized Cancer Nanomedicine
Speaker: Prof. Dr. Jan Mollenhauer, NanoCAN, University of Southern Denmark (DK) "Clinical Nanomedicine Targeted Medicine", The European CLINAM ETPN Summ...

By: TAUVOD

View original post here:

Mining Genome Information for New Starting Points in Personalized Cancer Nanomedicine - Video

Global Nanomedicine Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and size. The Global Nanomedicine Market research report renders lucid explanation to the reader to study fundamental attributes of Nanomedicine industry which includes lucrative business strategies, market demands, leading player of the market, and futuristic perspective through various angles.

Get Sample of Global Nanomedicine Market Research Report at: http://www.acquiremarketresearch.com/sample-request/243030/

AMRs Black Friday 2019 Corporate Sale begins and lasts from Thanksgiving till 6th December 2019.

As the Nanomedicine industry has been exhibiting substantial growth rate over the previous decade and expected to perform vigorously in forthcoming decades, it is being necessary to identify all investment opportunities, upcoming market threats, challenges, restraining factors, market dynamics, and technological advancements to strengthen footholds in Nanomedicine industry. The proposed research has studied all the above elements to render a thorough analysis to the reader that drives to achieve expected growth in their businesses.

Why B2B Companies Worldwide Rely on us to Grow and Sustain Revenues: Get a clear understanding of the Nanomedicine market, how it operates and the various stages of the value chain. Understand the current market situation and future growth potential of the Nanomedicine market till 2019 and plan strategies to gain from it. Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market and purchase decisions of buyers. Understand your competitors business structures, strategies and prospects, and respond accordingly. Make more informed business decisions with the help of insightful recommendations provided to succeed in the Nanomedicine market.

Browse Full Global Nanomedicine Market Report @ http://www.acquiremarketresearch.com/industry-reports/nanomedicine-market/243030/

Nanomedicine Market Major Players in Nanomedicine Market are: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

Most widely used downstream fields of Nanomedicine Market: Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology

Market Analysis by Types: Regenerative Medicine, In-vitro & In-vivo Diagnostics, Vaccines, Drug Delivery

Market Analysis by Geographies: This report is segmented into key Regions North America, Europe, China, Japan, Southeast Asia & India with Production Development, Sales, and Regional Trade & Forecast.

Get Discount on this Report: http://www.acquiremarketresearch.com/discount-request/243030/

The report elaborates competitive landscape considering mergers and acquisitions, joint ventures, partnerships, wind ups, strategic alliances, product developments, latest technological advancement, and research and developments in global Nanomedicine industry along with a forecast of emerging industry trends up to 2025.

Additionally, the report discusses lucrative business strategies of market competitors by lightning specific moves of competitors including business expansion, amalgamations, partnership deals, new product/service launches, and recently adopted technologies.

If you have any customized requirement need to be added, we will be happy to include this free of cost to enrich the final study.

For Any Query, Speak to Expert: [emailprotected]

Visit link:
Nanomedicine Market Share, Size 2019 Global Industry Future Trends, Growth, Strategies, Segmentation, In-depth Analysis Research Report by Foresight...

Global Healthcare Nanotechnology (Nanomedicine) Market comprehensive analysis of the business models, key ways, and individual market shares of some of the most outstanding players during this landscape. AN in-depth statement on the key influencing factors, market statistics in terms of revenues, segment-wise knowledge, region-wise knowledge, and country-wise knowledge are offered within the full study. with growth trends, numerous stakeholders like investors, CEOs, traders, suppliers, analysis & media, international Manager, Director, President, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization and others. This report focuses on Professional Global Healthcare Nanotechnology (Nanomedicine) Market 2020-2024 volume and value at Global level, regional level and company level.

Global Healthcare Nanotechnology (Nanomedicine) Market 2020report provides key statistics on the market status of the Healthcare Nanotechnology (Nanomedicine) Manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Healthcare Nanotechnology (Nanomedicine) Industry. The Healthcare Nanotechnology (Nanomedicine) industry report firstly announced the Healthcare Nanotechnology (Nanomedicine) Market fundamentals: type applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on.

Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

Healthcare Nanotechnology (Nanomedicine)market competition by top manufacturers/ Key player Profiled:

Abbott Laboratories,Combimatrix Corporation,GE Healthcare,Sigma-Tau Pharmaceuticals Inc.,Johnson and Johnson,Mallinckrodt Plc,Merck and Company Inc.,Nanosphere Inc.,Pfizer, Inc.,Celgene Corporation,.

And More

Get a Sample PDF of report @http://www.360marketupdates.com/enquiry/request-sample/13121392

Healthcare Nanotechnology (Nanomedicine) Market Segment by Type covers:

Healthcare Nanotechnology (Nanomedicine) Market Segment by Applications can be divided into:

Regional analysis covers:

Scope of theHealthcare Nanotechnology (Nanomedicine) MarketReport:

Fill the Pre-Order Enquiry form for the report @https://www.360marketupdates.com/enquiry/pre-order-enquiry/13121392

Key questions answered in the report:

Key Benefits

And More.

Look into Table of Content of Healthcare Nanotechnology (Nanomedicine) Market Report @https://www.360marketupdates.com/TOC/13121392#TOC

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information,growth rateof Healthcare Nanotechnology (Nanomedicine) market in 2025is also explained.Additionally, type wise and application wise consumptiontables andfiguresof Healthcare Nanotechnology (Nanomedicine) marketare also given.

Objective of Studies:

Buy this report (Price $ 3480 for a single-user license)@ https://www.360marketupdates.com/purchase/13121392

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

CONTACT US

Mr. Ajay More

Phone:+14242530807 / + 44 20 3239 8187

Email:[emailprotected]

Insect Repellent Market 2020: Global Industry Size, Share, Future Challenges, Revenue, Demand, Industry Growth and Top Players Analysis to 2024

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Healthcare Nanotechnology (Nanomedicine) Market 2024 Trends Forecast Analysis by Manufacturers, Regions, Type and Application Revenue, Gross Margin Forecast Analysis| 360 Market updates

See more here:
Healthcare Nanotechnology (Nanomedicine) Market 2024 Trends Forecast Analysis by Manufacturers, Regions, Type and Application Revenue, Gross Margin...

From diagnosis supported by artificial intelligence (AI), to 3D printing, virtual reality pain management, nanomedicine, and telemedicine technology is transforming the healthcare sector. In many ways, technology is a boon to the industry. According to the Association of American Medical Colleges, the US faces a shortage of between 40,800 and 104,900 physicians by 2030. Emerging technologies can help with this problem by expediting diagnoses and allowing physicians to focus on complex cases.

However, change almost always comes hand in hand with new risks. As healthcare organizations and professionals start to incorporate more technology into their businesses, they face heightened liability risks, malpractice or misdiagnosis claims, data privacy and cyber security concerns, and property exposures.

Greg Wideman (pictured), brokerage manager, professional and executive liability, Burns & Wilcox, commented: The healthcare insurance industry has become increasingly challenging due to emerging technology. Brokers are under pressure to find comprehensive coverage solutions for these new technologies and explain how they work in order to ensure adequate protection.

As healthcare organizations adopt new technologies, the expectation is that diagnoses and services will ultimately improve, in terms of both accuracy and efficiency. This social expectation has impacted the insurance industry by increasing the severity of healthcare claims. Should litigation arise, plaintiffs are being awarded more money than they were in the past because there is the belief that with new technologies in place, physicians should not be making mistakes.

A leading cause of loss in the healthcare insurance industry is misdiagnosis or no diagnosis of an existing condition. According to Wideman, this recurring problem can be largely attributed to physicians compensating for a shortage in their ranks by trying to get patients through the system as quickly as possible. Physicians are spending less time with patients and they are asking fewer questions. As a result, misdiagnosis numbers are on the rise, he added.

Some healthcare organizations are turning to telemedicine to enable virtual visits with doctors, nurses or other healthcare specialists, in order to speed up the consultation process. Offering video conferencing, messaging and mobile app-based communication gives patients the option to get check-ups and status updates from a remote location, but it also impacts physicians liability.

Physicians used to physically examine patients and do in-person diagnostic testing, but now a lot of that is being done over the internet or via an app, Wideman told Insurance Business. I think [telemedicine] opens up new liability for physicians because they are not in front of the patient and they are not necessarily asking the questions they would normally ask during an in-person consultation.

Another risk that is becoming increasingly problematic in the healthcare industry is data privacy and cyber liability.

There is a lot of consolidation going on in the healthcare industry right now, with small physician groups combining with hospitals, telemedicine providers, and pharmacy groups. This consolidation is presenting more cyber liability issues, Wideman added. Smaller physician offices struggle to implement the same cyber security practices and maintain the same IT support staff as the larger hospitals and healthcare systems. When they consolidate, that changes the exposure of the overall group.

In the era of electric medical records, cyber criminals are targeting healthcare organizations in order to extract and exploit the sensitive medical information that they hold. Issues could arise in the future with hackers compromising virtual healthcare tools or even commandeering robot-assisted surgical equipment.

In such a fast-paced and changing environment, healthcare providers should review their insurance coverage limits and deductibles with their insurance brokers to ensure they are properly protected, Wideman noted. As we start to see more complicated risks, it is important for brokers to ask in-depth questions to better understand the exposures they are being asked to place. Brokers can work with a wholesale partner, like Burns & Wilcox, for their expertise and trusted counsel in navigating solutions.

Originally posted here:
Technology transforming the healthcare industry - Insurance Business

Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

In 2018, the global Healthcare Nanotechnology (Nanomedicine) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

Request a sample of this report @https://www.orbisresearch.com/contacts/request-sample/2521730

This report focuses on the global Healthcare Nanotechnology (Nanomedicine) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Healthcare Nanotechnology (Nanomedicine) development in United States, Europe and China.

The key players covered in this studyAbbott LaboratoriesCombimatrix CorporationGE HealthcareSigma-Tau Pharmaceuticals Inc.Johnson & JohnsonMallinckrodt PlcMerck & Company Inc.Nanosphere Inc.Pfizer, Inc.Celgene Corporation

Market segment by Type, the product can be split intoBiochipImplant MaterialsMedical TextilesWound DressingOther

Market segment by Application, split intoTherapeuticDiagnosticResearch

Market segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

Place a purchase order @https://www.orbisresearch.com/contact/purchase-single-user/2521730

The study objectives of this report are:To analyze global Healthcare Nanotechnology (Nanomedicine) status, future forecast, growth opportunity, key market and key players.To present the Healthcare Nanotechnology (Nanomedicine) development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Healthcare Nanotechnology (Nanomedicine) are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents:

Chapter One: Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type (2014-2025)

1.4.2 Biochip

1.4.3 Implant Materials

1.4.4 Medical Textiles

1.4.5 Wound Dressing

1.4.6 Other

1.5 Market by Application

1.5.1 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2014-2025)

1.5.2 Therapeutic

1.5.3 Diagnostic

1.5.4 Research

1.6 Study Objectives

1.7 Years Considered

Chapter Two: Global Growth Trends

2.1 Healthcare Nanotechnology (Nanomedicine) Market Size

2.2 Healthcare Nanotechnology (Nanomedicine) Growth Trends by Regions

2.2.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (2014-2025)

2.2.2 Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

Chapter Three: Market Share by Key Players

3.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Manufacturers

3.1.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue by Manufacturers (2014-2018)

3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Manufacturers (2014-2018)

Continued.

Browse the complete report @https://www.orbisresearch.com/reports/index/global-healthcare-nanotechnology-nanomedicine-market-size-status-and-forecast-2019-2025

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: +1 (972)-362-8199 ; +91 895 659 5155

Read more here:
2019-2025 Healthcare Nanotechnology (Nanomedicine) Market Global Demand and Trends by Type, Application and Specification - News Description

New York, November 26, 2019: The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.

The Nanomedical Market is expected to exceed more than US$ 306 Billion by 2024 at a CAGR of 10.3% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/nanomedical-market

Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.

Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.

Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.

The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.

The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Nanomedical Market has been segmented as below:

The Nanomedical Market is segmented on the lines of Nanomedical Market, By Indication, Nanomedical Market, By Application, Nanomedical Market, By Modality, Nanomedical Market, By Region and Nanomedical Market, By Company.

Nanomedical Market, By Indication this market is segmented on the basis of Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases and Others. Nanomedical Market, By Application this market is segmented on the basis of Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines and Others. Nanomedical Market, By Modality this market is segmented on the basis of Treatments and Diagnostics. Nanomedical Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Nanomedical Market, By Company this market is segmented on the basis of Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company and Sigma-Tau Pharmaceuticals, Inc.

The report covers:

Report Scope:

The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

Reasons to Buy this Report:

Request Sample Report from here: https://www.marketresearchengine.com/nanomedical-market

Table of Contents:

Other Related Market Research Reports:

Biologic and Medical Imaging Reagents Market Overview and Share Forecasted to 2024 MRE Report

Hospital Supplies Market 2019 Perceive Substantial Growth During 2024 MRE Report

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

View original post here:
Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 - Markets Gazette 24

COVID-19s outbreak has coincided with investments flooding into nanomedicine healthcare companies, according to the latest data. The investment monitoring platform reported that the sector benefited by 1.7bn in 2020 - 1.1bn more than the year before.

Nano Magazine has highlighted a report by Market DataForecastthat the global nanomedicine market, worth $141.34 billion in 2020, will rise to $258.11bn by 2025. The report also highlights a huge upsurge of investment support from governments and funds to develop nano therapies for vaccines, diagnostic imaging, regenerative medicine, and drug delivery following the impact of COVID-19.

Furthermore, nanomedicine offers huge advantages for wider healthcare, also affected by the pandemic and Long-COVID after-effects upon cardiovascular, respiratory, neurological, immunological-related diseases.

This aligns with investment monitoring platform Pitchbooks forecast that health tech investment overall will top $10 trillion by 2022 and that nanomedicine investment has grown the sector by 250% in the last five years.

Median nanotech healthcare deal sizes have also doubled since 2019, from 1 million to 2m in 2021, while the number of deals in 2020 was greater than ever, overtaking 100 deals in a single year for the first time.

Nanomedicine is transforming healthcare innovation and delivering early intervention and targeted drug delivery and testingNanomedicine is transforming healthcare innovation and delivering early intervention and targeted drug delivery and testing

Investment is already aiding innovation as nanotech researchers and scientists work to improve biomedical devices such as prosthetics, provide new cancer treatments, and develop bone healing therapies, along with more innovations that could transform global healthcare.

Nanotech researchers have found nanobodies that block the COVID-19 and, potentially, other coronaviruses from entering cells and developed mask designs at nanoscale making them both cheaper and more effective.

The fast global response to the pandemic was also enabled by nanotechnology, being pivotal in Pfizer and AstraZeneca vaccine development and Innova Medical Groups 30-minute lateral flow COVID tests.

World Nano Foundation co-founder Paul Stannard said COVID-19 highlighted weaknesses in healthcare systems across the developed world, proving that long-term, innovative solutions are needed to enable change and prevent future pandemics, with nanomedicine playing an ever-greater role in this transformation of global healthcare.

And while impressed by rising investments in and recognition for the nanotech sector, he warned against any let-up in this trend:

Nanotechnology is not only crucial to our current healthcare systems, but researchers and scientists in this field are on the cusp of therapies, devices, and innovation that will revolutionize how we move forward.

To ensure pandemic preparedness, high-quality healthcare, and longevity, we must invest in nano healthtech and care innovations.

His message was echoed by Kojo Annan (son of late and former UN secretary-general Kofi Annan) who is a general partner in the Luxembourg-based Vector Innovation Fund, which recently launched a sub-fund raising an initial $300m for pandemic protection and preparedness.

Annan said: A virtuous circle is developing between investment and healthtech. Lately, we have seen the development of multiple vaccines, acceleration of technologies linked to decoding the genome, the rise of nanomedicine and the use of artificial intelligence to monitor infectious diseases and new pathogens.

More investment in sustainable healthtech funding can only accelerate this trend, bringing the fairer and global distribution of healthcare, greater affordability, and preventive and early intervention healthcare, all ultimately improving the longevity of life.

The pandemic has also transformed telemedicine investment and demonstrated that nanoscience and innovation could deliver more resilient societies and ecosystems for healthcare.

Korea IT Times

More:
Surging nanomedicine virtuous circle develops between investment and healthtech - Korea IT Times

DataIntelo, one of the worlds prominent market research firms has released a new report on Global Nanomedicine Market. The report contains crucial insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Nanomedicine market to figure out and study market needs, market size, and competition. The report talks about the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players.

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Nanomedicine market and what the future holds for it. The published report is designed using a vigorous and thorough research methodology and DataIntelo is also known for its data accuracy and granular market reports.

You can buy the report @ https://dataintelo.com/checkout/?reportId=81345

A complete analysis of the competitive scenario of the Nanomedicine market is depicted by the report. The report has a vast amount of data about the recent product and technological developments in the markets. It has a wide spectrum of analysis regarding the impact of these advancements on the markets future growth, wide-range of analysis of these extensions on the markets future growth.

Nanomedicine market report tracks the data since 2015 and is one of the most detailed reports. It also contains data varying according to region and country. The insights in the report are easy to understand and include pictorial representations. These insights are also applicable in real-time scenarios.

Request Free Sample Report @ https://dataintelo.com/request-sample/?reportId=81345

Components such as market drivers, restraints, challenges, and opportunities for Nanomedicine are explained in detail. Since the research team is tracking the data for the market from 2015, therefore any additional data requirement can be easily fulfilled.

Some of the prominent companies that are covered in this report:

CombimatrixAblynxAbraxis BioscienceCelgeneMallinckrodtArrowhead ResearchGE HealthcareMerckPfizerNanosphereEpeius BiotechnologiesCytimmune SciencesNanospectra Biosciences

*Note: Additional companies can be included on request

The industry looks to be fairly competitive. To analyze any market with simplicity the market is fragmented into segments, such as its product type, application, technology, end-use industry, etc. Segmenting the market into smaller components helps in understanding the dynamics of the market with more clarity. Data is represented with the help of tables and figures that consist of a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc. Another key component that is included in the report is the regional analysis to assess the global presence of the Nanomedicine market.

Following is the gist of segmentation:

By Application:

Segmentation encompasses oncologyInfectious diseasesCardiologyOrthopedicsOthers

By Type:

Quantum dotsNanoparticlesNanoshellsNanotubesNanodevices

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

You can also go for a yearly subscription of all the updates on the Nanomedicine market.

Reasons you should buy this report:

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Nanomedicine Market Overview

Nanomedicine Supply Chain Analysis

Nanomedicine Pricing Analysis

Global Nanomedicine Market Analysis and Forecast by Type

Global Nanomedicine Market Analysis and Forecast by Application

Global Nanomedicine Market Analysis and Forecast by Sales Channel

Global Nanomedicine Market Analysis and Forecast by Region

North America Nanomedicine Market Analysis and Forecast

Latin America Nanomedicine Market Analysis and Forecast

Europe Nanomedicine Market Analysis and Forecast

Asia Pacific Nanomedicine Market Analysis and Forecast

Middle East & Africa Nanomedicine Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, please reach out to us @ https://dataintelo.com/enquiry-before-buying/?reportId=81345

About DataIntelo:

DataIntelo has a vast experience in designing tailored market research reports in various industry verticals. We also have an urge to provide complete client satisfaction. We cover in-depth market analysis, which consists of producing lucrative business strategies for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current market scenario.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also offer ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo

Here is the original post:
Nanomedicine Market (2020-2026) | Where Should Participant Focus To Gain Maximum ROI | Exclusive Report By DataIntelo - Aerospace Journal